TRIB Trinity Biotech Corp: Expected earnings per share growth for next year

Trinity Biotech Corp (TRIB) - corporate logo

Reviewing the estimated annual EPS growth for the next period on GURU.Markets, it is evident that the latest figure stands at 0.00. This trend reflects the introduction of portable glucose monitoring systems into a saturated market. The stability of these indicators confirms the macro-resilience of the medical diagnostics niche, which remains independent of economic cycles. Currently, Trinity Biotech plc (TRIB) management is optimizing expenses and restructuring the business to return to profitability.

Trinity Biotech PLC (TRIB): Expected earnings per share trend next year from 07/04/2022 to 11/10/2026

Analytical breakdowns for Trinity Biotech (TRIB)

- price and consensus price forecast:
Price Chart Trinity Biotech PLC|TRIB - Analyst Median Target
- company stock capitalization data:
Market Valuation Trinity Biotech|TRIB - Aggregate Business Value
- book capitalization information:
Net Assets per Single Share Trinity Biotech|TRIB - Accounting Value of Company|Market Capitalization to Book Value Ratio trinitybiotech.com|TRIB - Company Total Asset Base
- debt burden and liquidity indicators:
Debt to Equity Trinity Biotech plc|TRIB - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Trinity Biotech PLC|TRIB - Company Total Debt Obligations|Debt to Book Value Trinity Biotech|TRIB - Amount of Long-Term Liabilities|Company Current Liabilities Trinity Biotech|Quick Liquidity Indicator trinitybiotech.com
- net income and valuation ratios data:
TRIB - Final Profit|Projected Future Earnings Trinity Biotech plc|TRIB - Price to Earnings Ratio|Forward P/E Multiple Trinity Biotech PLC|TRIB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Trinity Biotech|TRIB - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Trinity Biotech|TRIB - Earnings per share for the last four quarters|Quarterly EPS earnings growth trinitybiotech.com|TRIB - Earnings per share growth rate in current year|Earnings growth forecast for next year Trinity Biotech plc
Initial company analysis:Trinity Biotech plc
Core merchandise of Trinity Biotech

Stable demand for diabetes and HIV diagnostics creates a predictable cash flow for Trinity Biotech plc (TRIB), minimizing operational risks. The expected profit dynamics for the coming year mathematically express the difference between current and projected EPS, reflecting market expectations for the capitalization of this potential. By analyzing the trend of consensus EPS forecasts for the coming year, an investor assesses the business's sensitivity to external shocks without a time lag between reports.

Direct competitors

Net earnings per share growth forecast for next year Agilent Tech|Quest Corp (DGX) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year ILMN (Illumina, Inc.)|Projected earnings per share increase next year EXAS|Net earnings per share growth forecast for next year Revvity RVTY|Expected earnings per share trend next year BIO|Anbio Tech - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Nordion SHC|QuidelOrtho (QDEL) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year OPK|CDNA (CareDx, Inc.) - Earnings growth forecast for next year|Maravai LifeSciences Holdings (MRVI) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year FLGT (Fulgent Corp)|Projected earnings per share increase next year LAB|Cytek Biosciences, Inc. - Expected earnings per share growth for next year|orasure.com (OSUR) - Expected net earnings per share growth next year|XGN: Expected earnings per share growth for next year|Expected earnings per share trend next year MDXH (MDxHealth S.A.)|LUCD: Earnings growth forecast for next year|PRE (Prenetics) - Net earnings per share growth forecast for next year|IMDX (Insight Molecular Diagnostics, Inc.) - Earnings growth forecast for next year|prophaselabs.com (PRPH) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ainos (AIMD)|CODX - Expected net earnings per share growth next year|Heart Test Laboratories Inc. - Expected earnings per share growth for next year|Projected earnings per share increase next year BMRA (Biomerica Inc)|Cardio Diagnostics Holdings, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year onconetix.gcs-web.com|VRAX: Earnings growth forecast for next year|Expected earnings per share growth for next year Bluejay Diagnostics Inc|AWH (Vermillion) - Earnings growth forecast for next year|AXDX: Expected earnings per share trend next year|Expected earnings per share growth for next year CNTG (Centogene NV)|ENZ (enzo.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Fresh2 Group FRES|GENE (Genetic Technologies Ltd) - Net earnings per share change forecast for next year|ME - Net earnings per share growth forecast for next year|PMD: Net earnings per share growth forecast for next year